{"schema_version":"secwatch.filing_event.v1","accession":"0001035267-22-000123","form_type":"8-K","ticker":"ISRG","cik":"0001035267","company_name":"INTUITIVE SURGICAL INC","filed_at":"2022-07-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.708369+00:00","generated_at":"2026-06-24T09:48:06.975615+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Q2 GAAP net income $308M ($0.85 EPS) down 40% YoY; revenue $1.52B up 4%","bullets":["Worldwide da Vinci procedures grew ~14% YoY; system placements 279 (down 15%).","Instruments & accessories revenue $895M (+12%); systems revenue $375M (-15%).","Non-GAAP net income $415M ($1.14 per share) vs $475M ($1.30) in Q2 2021.","Repurchased $500M of common stock in Q2; Board increased buyback authorization to $3.5B.","Ended Q2 with $8.18B cash; cash decreased $226M due to buybacks and capex."],"urls":{"canonical":"https://secwatch.observer/filing/0001035267-22-000123","json":"https://secwatch.observer/filing/0001035267-22-000123.json","markdown":"https://secwatch.observer/filing/0001035267-22-000123.md","text":"https://secwatch.observer/filing/0001035267-22-000123.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1035267/000103526722000123/0001035267-22-000123-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1035267/000103526722000123/isrg-20220721.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T09:48:06.975615+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}